NCT00000196
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 5
ConditionsOpioid-Related Disorders
DrugsNaltrexone
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Behavioral, physiological, neuroendocrine response to yohimbine
- Status
- Withdrawn
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Behavioral, physiological, neuroendocrine response to yohimbine
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 4 - 4Opioid-Related DisordersNCT00000195Yale University
Completed
Phase 4
The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of DreamsNeuroscience of Dreaming, HealthyNCT02792140University of Bern32
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 1 - 1Opioid-Related DisordersNCT00000192Yale University
Terminated
Phase 3
Naltrexone in Borderline Personality DisorderBorderline Personality DisorderNCT00124839Central Institute of Mental Health, Mannheim48
Completed
Phase 2
Effects of Naltrexone on Nicotine ReinforcementTobacco DependenceNCT00270231University of Pennsylvania64